Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
CDH1 gene
Germline variants
Hereditary diffuse gastric cancer
Women cancer risk
Journal
Journal of cancer research and clinical oncology
ISSN: 1432-1335
Titre abrégé: J Cancer Res Clin Oncol
Pays: Germany
ID NLM: 7902060
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
30
06
2023
accepted:
18
08
2023
medline:
2
11
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
ppublish
Résumé
The objective of this study was to determine the male and female frequency of diffuse gastric cancer (DGC), the age at diagnosis, and the country of origin in a selected population with germline CDH1 variants from families with the hereditary diffuse gastric cancer (HDGC) syndrome. Relevant literature dating from 1998 to 2021 was systematically searched for data on CDH1 gene. The Wilcoxon rank sum test and the Chi-square test were used to estimate if the difference observed between patients with gastric cancer (GC) and unaffected individuals was significant. We identified 80 families fulfilling the established clinical criteria for HDGC CDH1 genetic screening. There were more women than men with DGC and germline CDH1 variant (65.5%). Stratifying the age at diagnosis, we identified an association between DGC, positive CDH1 screening and young women (≤ 40 years) (p = 0.015). The mean age at diagnosis was 39.6 ys for women and 42.5 ys for men. There was an association between CDH1 carrier status and DGC (p = 0.021). Young women carrying germline CDH1 variants with DGC are comparatively frequent in the HDGC syndrome, and potentially at higher risk to develop DGC particularly in low-incidence areas for GC.
Identifiants
pubmed: 37639007
doi: 10.1007/s00432-023-05318-5
pii: 10.1007/s00432-023-05318-5
doi:
Substances chimiques
Cadherins
0
CDH1 protein, human
0
Antigens, CD
0
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
16147-16155Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Bardram L, Hansen TV, Gerdes AM, Timshel S, Friis-Hansen L, Federspiel B (2014) Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study. Fam Cancer 13(2):231–242
pubmed: 24389957
doi: 10.1007/s10689-013-9698-8
Betés M, Alonso-Sierra M, Valentí V, Patiño A (2017) A multidisciplinary approach allows identification of a new pathogenic CDH1 germline missense mutation in a hereditary diffuse gastric cancer family. Dig Liver Dis 49(7):825–826
pubmed: 28487081
doi: 10.1016/j.dld.2017.04.006
Black MD, Kaneshiro R, Lai JI, Shimizu DM (2014) Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report. Hawaii J Med Public Health 73(7):204–207
pubmed: 25089230
pmcid: 4100282
Caggiari L, Miolo G, Canzonieri V, De Zorzi M, Alessandrini L, Corona G, Cannizzaro R, Santeufemia DA, Cossu A, Buonadonna A, De Re V (2018) A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach. Cancer Biol Ther 19(4):254–259
pubmed: 29131691
doi: 10.1080/15384047.2017.1394540
Caron O, Schielke A, Svrcek M, Fléjou JF, Garzon J, Olschwang S, Sézeur A (2008) Usefulness of prophylactic gastrectomy in a novel large hereditary diffuse gastric cancer (HDGC) family. Am J Gastroenterol 103(8):2160–2161
pubmed: 18796125
doi: 10.1111/j.1572-0241.2008.01982_17.x
Choi HG, Chun W, Jung KH (2022) Association between gastric cancer and the family history of gastric cancer: a cross-sectional study using Korean Genome and Epidemiology Study data. Eur J Cancer Prev 31:408–414
pubmed: 34860707
doi: 10.1097/CEJ.0000000000000724
Corso G, Corso F, Bellerba F, Carneiro P, Seixas S, Cioffi A, La Vecchia C, Magnoni F, Bonanni B, Veronesi P, Gandini S, Figueiredo J (2021) Geographical distribution of E-cadherin germline mutations in the context of diffuse gastric cancer: a systematic review. Cancers (basel) 13:1269
pubmed: 33809393
doi: 10.3390/cancers13061269
Corso G, Magnoni F, Massari G, Trovato CM, De Scalzi AM, Vicini E, Bonanni B, Veronesi P, Galimberti V, Bagnardi V (2022) CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome. J Med Genet 59:313–317
pubmed: 34952833
doi: 10.1136/jmedgenet-2021-108226
Dang DNT, Nguyen HTT, Ngo HD, Tran BM, Vu AD, Dang HQ, Ta VT (2021) A novel stop codon mutation in exon 5 (c.639G>A) of the cadherin-1 gene in a Vietnamese man with hereditary diffuse gastric cancer: a case report. J Med Case Rep 15(1):263
pubmed: 33941229
pmcid: 8094596
doi: 10.1186/s13256-021-02837-y
De Scalzi AM, Bonanni B, Galimberti V, Veronesi P, Pravettoni G, Corso G (2019) E-cadherin germline mutations in Māori population. Future Oncol 15:1291–1294
pubmed: 30977389
doi: 10.2217/fon-2018-0834
Dussaulx-Garin L, Blayau M, Pagenault M, Le Berre-Heresbach N, Raoul JL, Campion JP, David V, Bretagne JF (2001) A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. Eur J Gastroenterol Hepatol 13(6):711–715
pubmed: 11434599
doi: 10.1097/00042737-200106000-00016
El-Husny A, Raiol-Moraes M, Amador M, Ribeiro-Dos-Santos AM, Montagnini A, Barbosa S, Silva A, Assumpção P, Ishak G, Santos S, Pinto P, Cruz A, Ribeiro-Dos-Santos  (2016) CDH1 mutations in gastric cancer patients from northern Brazil identified by next-generation sequencing (NGS). Genet Mol Biol 39(2):189–198
pubmed: 27192129
pmcid: 4910547
doi: 10.1590/1678-4685-gmb-2014-0342
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 2:3
Frebourg T, Oliveira C, Hochain P, Karam R, Manouvrier S, Graziadio C, Vekemans M, Hartmann A, Baert-Desurmont S, Alexandre C, Lejeune Dumoulin S, Marroni C, Martin C, Castedo S, Lovett M, Winston J, Machado JC, Attié T, Jabs EW, Cai J, Pellerin P, Triboulet JP, Scotte M, Le Pessot F, Hedouin A, Carneiro F, Blayau M, Seruca R (2006) Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet 43(2):138–142
pubmed: 15831593
pmcid: 2564630
doi: 10.1136/jmg.2005.031385
Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BA, Caldas C (1998) Identification of germline E-cadherin mutations in gastric cancer families of European origin. Cancer Res 58(18):4086–4089
pubmed: 9751616
Ghaffari SR, Rafati M, Sabokbar T, Dastan J (2010) A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer. Eur J Surg Oncol 36(6):559–562
pubmed: 20471195
doi: 10.1016/j.ejso.2010.04.001
GBD Stomach Cancer Collaborators (2020) The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 5:42–54
doi: 10.1016/S2468-1253(19)30328-0
Giacosa A, Barale R, Bavaresco L, Gatenby P, Gerbi V, Janssens J, Johnston B, Kas K, La Vecchia C, Mainguet P, Morazzoni P, Negri E, Pelucchi C, Pezzotti M, Rondanelli M (2013) Cancer prevention in Europe: the Mediterranean diet as a protective choice. Eur J Cancer Prev 22:90–95
pubmed: 22644232
doi: 10.1097/CEJ.0b013e328354d2d7
Giraldi L, Stojanovic J, Arzani D, Persiani R, Hu J, Johnson KC, Zhang ZF, Ferraroni M, Palli D, Yu GP, La Vecchia C, Pelucchi C, Lunet N, Ferro A, Malekzadeh R, Muscat J, Zaridze D, Maximovich D, Aragones N, Martin V, Vioque J, Navarrete-Munoz EM, Pakseresht M, Negri E, Rota M, Pourfarzi F, Mu L, Kurtz RC, Lagiou A, Lagiou P, Pastorino R, Boccia S (2023) Adult height and risk of gastric cancer: a pooled analysis within the stomach cancer pooling project. Eur J Cancer Prev 32(3):215–221
pubmed: 32925512
doi: 10.1097/CEJ.0000000000000613
Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, Rajput A, Wiesner GL, Lindor NM, Burgart LJ, Toro TT, Lee D, Limacher JM, Shaw DW, Findlay MP, Reeve AE (1999) E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 14(3):249–255
pubmed: 10477433
doi: 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9
Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392(6674):402–405
pubmed: 9537325
doi: 10.1038/32918
Gullo I, Devezas V, Baptista M, Garrido L, Castedo S, Morais R, Wen X, Rios E, Pinheiro J, Pinto-Ribeiro I, Ferreira RM, Preto J, Santos-Antunes J, Marques M, Campos M, Almeida F, Espinheira MDC, Amil Dias J, Figueiredo C, Oliveira C, Trindade E, Carneiro F (2018) Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease. Gastrointest Endosc 87(6):1566–1575
pubmed: 29454568
doi: 10.1016/j.gie.2018.02.008
Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K, Zogopoulos G, Santos TA, Claro I, Carvalho J, Nielsen C, Padilla S, Lum A, Talhouk A, Baker-Lange K, Richardson S, Lewis I, Lindor NM, Pennell E, MacMillan A, Fernandez B, Keller G, Lynch H, Shah SP, Guilford P, Gallinger S, Corso G, Roviello F, Caldas C, Oliveira C, Pharoah PD, Huntsman DG (2015) Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol 1:23–32
pubmed: 26182300
doi: 10.1001/jamaoncol.2014.168
Hirakawa M, Takada K, Sato M, Fujita C, Hayasaka N, Nobuoka T, Sugita S, Ishikawa A, Mizukami M, Ohnuma H, Murase K, Miyanishi K, Kobune M, Takemasa I, Hasegawa T, Sakurai A, Kato J (2020) Case series of three patients with hereditary diffuse gastric cancer in a single family: three case reports and review of literature. World J Gastroenterol 26(42):6689–6697
pubmed: 33268956
pmcid: 7673959
doi: 10.3748/wjg.v26.i42.6689
Ithurralde-Argerich J, Rosner L, Rizzolo M, Faerberg A, Puma R, Ferro D, Duque C, Kujaruk M, Cuenca-Abente F (2021) Laparoscopic prophylactic total gastrectomy for hereditary diffuse gastric cancer in CDH1 mutation carriers. J Laparoendosc Adv Surg Tech A 31(7):729–737
pubmed: 34097461
doi: 10.1089/lap.2021.0239
Jiang Y, Wan YL, Wang ZJ, Zhao B, Zhu J, Huang YT (2004) Germline E-cadherin gene mutation screening in familial gastric cancer kindreds. Zhonghua Wai Ke Za Zhi 42(15):914–917
pubmed: 15363252
Katona BW, Clark DF, Domchek SM (2020) CDH1 on multigene panel testing: look before you leap. J Natl Cancer Inst 112(4):330–334
pubmed: 31841163
doi: 10.1093/jnci/djz229
Keller G, Vogelsang H, Becker I, Hutter J, Ott K, Candidus S, Grundei T, Becker KF, Mueller J, Siewert JR, Höfler H (1999) Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155(2):337–342
pubmed: 10433926
pmcid: 1866861
doi: 10.1016/S0002-9440(10)65129-2
Kluijt I, Siemerink EJ, Ausems MG, van Os TA, de Jong D, Simões-Correia J, van Krieken JH, Ligtenberg MJ, Figueiredo J, van Riel E, Sijmons RH, Plukker JT, van Hillegersberg R, Dekker E, Oliveira C, Cats A, Hoogerbrugge N (2012) CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. Int J Cancer 131(2):367–376
pubmed: 22020549
doi: 10.1002/ijc.26398
López M, Cervera-Acedo C, Santibáñez P, Salazar R, Sola JJ, Domínguez-Garrido E (2016) A novel mutation in the CDH1 gene in a Spanish family with hereditary diffuse gastric cancer. Springerplus 5(1):1181
pubmed: 27512640
pmcid: 4961654
doi: 10.1186/s40064-016-2852-7
Lynch HT, Kaurah P, Wirtzfeld D, Rubinstein WS, Weissman S, Lynch JF, Grady W, Wiyrick S, Senz J, Huntsman DG (2008) Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer 112(12):2655–2663
pubmed: 18442100
doi: 10.1002/cncr.23501
Lyons K, Le LC, Pham YT, Borron C, Park JY, Tran CTD, Tran TV, Tran HT, Vu KT, Do CD, Pelucchi C, La Vecchia C, Zgibor J, Boffetta P, Luu HN (2019) Gastric cancer: epidemiology, biology, and prevention: a mini review. Eur J Cancer Prev 28:397–412
pubmed: 31386635
doi: 10.1097/CEJ.0000000000000480
Martínez Valenzuela C, Castelán-Maldonado EE, Carvajal-Zarrabal O, Calderón-Garcidueñas AL (2020) First report of a Mexican family with mutation in the CDH1 gene. Mol Genet Genomic Med 8(11):e1208
pubmed: 32886433
pmcid: 7667379
doi: 10.1002/mgg3.1208
Mayrbaeurl B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W, Knoflach P, Duba HC, Hoefler H, Thaler J (2010) Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. Eur J Gastroenterol Hepatol 22(3):306–310
pubmed: 19474748
doi: 10.1097/MEG.0b013e32832bab9a
More H, Humar B, Weber W, Ward R, Christian A, Lintott C, Graziano F, Ruzzo AM, Acosta E, Boman B, Harlan M, Ferreira P, Seruca R, Suriano G, Guilford P (2007) Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat 28(2):203
pubmed: 17221870
doi: 10.1002/humu.9473
Norero E, Alarcon MA, Hakkaart C, de Mayo T, Mellado C, Garrido M, Aguayo G, Lagos M, Torres J, Calvo A, Guilford P, Corvalan AH (2019) Identification of c.1531C>T pathogenic variant in the CDH1 gene as a novel germline mutation of hereditary diffuse gastric cancer. Int J Mol Sci 20(20):4980
pubmed: 31600923
pmcid: 6829381
doi: 10.3390/ijms20204980
Norton JA, Ham CM, Van Dam J, Jeffrey RB, Longacre TA, Huntsman DG, Chun N, Kurian AW, Ford JM (2007) CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 245(6):873–879
pubmed: 17522512
pmcid: 1876967
doi: 10.1097/01.sla.0000254370.29893.e4
Obermair F, Rammer M, Burghofer J, Malli T, Schossig A, Wimmer K, Kranewitter W, Mayrbaeurl B, Duba HC, Webersinke G (2019) Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature. Fam Cancer 18(2):253–260
pubmed: 30306390
doi: 10.1007/s10689-018-0111-5
Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE, Seruca R, Caldas C (2002) Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat 19(5):510–517
pubmed: 11968083
doi: 10.1002/humu.10068
Oliveira C, de Bruin J, Nabais S, Ligtenberg M, Moutinho C, Nagengast FM, Seruca R, van Krieken H, Carneiro F (2004a) Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene 23(12):2236–2240
pubmed: 14661064
doi: 10.1038/sj.onc.1207335
Oliveira C, Ferreira P, Nabais S, Campos L, Ferreira A, Cirnes L, Alves CC, Veiga I, Fragoso M, Regateiro F, Dias LM, Moreira H, Suriano G, Machado JC, Lopes C, Castedo S, Carneiro F, Seruca R (2004b) E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer 40(12):1897–1903
pubmed: 15288293
doi: 10.1016/j.ejca.2004.04.027
Pena-Couso L, Perea J, Melo S, Mercadillo F, Figueiredo J, Sanches JM, Sánchez-Ruiz A, Robles L, Seruca R, Urioste M (2018) Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer. Eur J Hum Genet 26(9):1348–1353
pubmed: 29769627
pmcid: 6117277
doi: 10.1038/s41431-018-0173-8
Richards FM, McKee SA, Rajpar MH, Cole TR, Evans DG, Jankowski JA, McKeown C, Sanders DS, Maher ER (1999) Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet 8(4):607–610
pubmed: 10072428
doi: 10.1093/hmg/8.4.607
Roberts ME, Ranola JMO, Marshall ML, Susswein LR, Graceffo S, Bohnert K, Tsai G, Klein RT, Hruska KS, Shirts BH (2019) Comparison of CDH1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers. JAMA Oncol 5:1325–1331
pubmed: 31246251
pmcid: 6604087
doi: 10.1001/jamaoncol.2019.1208
Rodriguez-Sanjuan JC, Fontalba A, Mayorga M, Bordin MC, Hyland SJ, Trugeda S, Garcia RA, Gomez-Fleitas M, Fernandez F, Caldas C, Fernandez-Luna JL (2006) A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. Eur J Surg Oncol 32(10):1110–1113
pubmed: 16870389
doi: 10.1016/j.ejso.2006.06.006
Rogers WM, Dobo E, Norton JA, Van Dam J, Jeffrey RB, Huntsman DG, Kingham K, Chun N, Ford JM, Longacre TA (2008) Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am J Surg Pathol 32(6):799–809
pubmed: 18391748
doi: 10.1097/PAS.0b013e31815e7f1a
Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Berardi A, Garosi L, Suriano G, Vindigni C, De Stefano A, Leoncini L, Seruca R, Pinto E (2007) Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol 33(4):448–451
pubmed: 17126523
doi: 10.1016/j.ejso.2006.10.028
Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, Negri E, Bosetti C, La Vecchia C (2020) Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev 29:367–381
pubmed: 32740162
doi: 10.1097/CEJ.0000000000000594
Shah MA, Salo-Mullen E, Stadler Z, Ruggeri JM, Mirander M, Pristyazhnyuk Y, Zhang L (2012) De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer. Clin Genet 82(3):283–287
pubmed: 21696387
doi: 10.1111/j.1399-0004.2011.01744.x
Sugimoto S, Yamada H, Takahashi M, Morohoshi Y, Yamaguchi N, Tsunoda Y, Hayashi H, Sugimura H, Komatsu H (2014) Early-onset diffuse gastric cancer associated with a de novo large genomic deletion of CDH1 gene. Gastric Cancer 17(4):745–749
pubmed: 23812922
doi: 10.1007/s10120-013-0278-2
Van Domselaar F, Correa D, Vaccaro C, Redal M, Van Domselaar R, Huntsman D, Kaurah P, Senz J, Lynch H (2007) Cáncer gástrico difuso hereditario (CGDH): presentación de una familia con una nueva mutación del gen CDH1 [Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]. Acta Gastroenterol Latinoam 37(3):158–163
pubmed: 17955726
Xicola RM, Li S, Rodriguez N, Reinecke P, Karam R, Speare V, Black MH, LaDuca H, Llor X (2019) Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria. J Med Genet 56(12):838–843
pubmed: 31296550
doi: 10.1136/jmedgenet-2019-105991
Yamada M, Fukagawa T, Nakajima T, Asada K, Sekine S, Yamashita S, Okochi-Takada E, Taniguchi H, Kushima R, Oda I, Saito Y, Ushijima T, Katai H (2014) Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1. Gastric Cancer 17(4):750–756
pubmed: 24037103
doi: 10.1007/s10120-013-0298-y
Yamada H, Shinmura K, Ito H, Kasami M, Sasaki N, Shima H, Ikeda M, Tao H, Goto M, Ozawa T, Tsuneyoshi T, Tanioka F, Sugimura H (2011) Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population. Cancer Sci 102(10):1782–1788
pubmed: 21777349
doi: 10.1111/j.1349-7006.2011.02038.x
Yelskaya Z, Bacares R, Salo-Mullen E, Somar J, Lehrich DA, Fasaye GA, Coit DG, Tang LH, Stadler ZK, Zhang L (2016) CDH1 Missense Variant c.1679C>G (p.T560R) Completely Disrupts Normal Splicing through Creation of a Novel 5’ Splice Site. PLoS ONE 11(11):e0165654
pubmed: 27880784
pmcid: 5120775
doi: 10.1371/journal.pone.0165654
Zhang L, Xiao A, Ruggeri J, Bacares R, Somar J, Melo S (2014) The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutation. Mutat Res 770:106–111
pubmed: 25771876
doi: 10.1016/j.mrfmmm.2014.10.001
Zhang YJ, Yang Y, Wei Q, Xu T, Zhang XT, Gao J, Tan SY, Liu BR, Zhang JD, Chen XB, Wang ZJ, Qiu M, Wang X, Shen L, Wang XC (2021) A multicenter study assessing the prevalence of germline genetic alterations in Chinese gastric-cancer patients. Gastroenterol Rep (Oxf) 9(4):339–349
pubmed: 34567566
doi: 10.1093/gastro/goab020